AGIOS PHARMACEUTICALS, INC. Inventory
AGIOS PHARMACEUTICALS, INC. (AGIO) had Inventory of $35.75 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2026-07-30
- 2026-06-30: Inventory, Net $35.75M.
- 2026-03-31: Inventory, Net $35.09M.
- 2025-12-31: Inventory, Net $32.92M.
- 2025-09-30: Inventory, Net $32.03M.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $35.75M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $35.09M 10-Q · filed 2026-04-29 |
| 2025-12-31 | $32.92M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $32.03M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $30.85M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $29.61M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $27.62M 10-K · filed 2026-02-12 |
| 2024-09-30 | $26.43M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $23.94M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $23.07M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $19.08M 10-K · filed 2025-02-13 |
| 2023-09-30 | $17.27M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $15.67M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $11.37M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $8.49M 10-K · filed 2024-02-15 |
| 2022-09-30 | $5.18M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $4.06M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $2.48M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-23 |
| 2020-12-31 | $14.70M 10-K · filed 2021-02-25 |
| 2020-09-30 | $11.37M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $11.23M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $9.78M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $7.33M 10-K · filed 2021-02-25 |
| 2019-09-30 | $5.85M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $4.66M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $2.33M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $869.00K 10-K · filed 2020-02-19 |
| 2018-09-30 | $863.00K 10-Q · filed 2018-11-01 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |